Barbra A. Dickerman, Arin L. Madenci, Hanna Gerlovin, Katherine E. Kurgansky, Jessica K. Wise, Michael J. Figueroa Muñiz, Brian R. Ferolito, David R. Gagnon, J. Michael Gaziano, Kelly Cho, Juan P. Casas, and Miguel A. Hernán
June 13, 2022
JAMA Internal Medicine
Harvard T.H. Chan School of Public Health

In this cohort study of 433,672 US veterans, the research team compared the frequency of adverse events experienced by recipients of the Pfizer (BNT162b2) and Moderna (mRNA-1273) COVID-19 vaccines. In comparison with the Moderna product, the Pfizer injections significantly elevated the risk of eight (8) of the 14 adverse events assessed:

  • Hemorrhagic stroke: 1.24 risk ratio (0.72, 1.44; 95% CI)

  • Ischemic stroke: 1.18 (1.02, 1.28)

  • Myocardial infarction: 1.36 (1.20, 1.53)

  • Other thromboembolic: 1.24 (1.10, 1.38)

  • Myocarditis or pericarditis: 1.92 (1.00, 2.50)

  • Arrhythmia: 1.13 (1.02, 1.17)

  • Kidney injury: 1.21 (1.13, 1.35)

  • Pneumonia: 1.23 (1.12, 1.34)

Source: eTable 5 on page 50 of the supplemental content

Large VA COVID vaccine safety study done by Harvard researchers in 2022 shows statistically significant 36% higher risk of heart attack in people who took Pfizer
https://kirschsubstack.com/p/large-va-covid-vaccine-safety-study 

document
adverse events,COVID-19,heart disorders,mRNA,vaccines,vascular system issues